Cefob-1.5g Injection

Cefuroxime Sodium 1500 mg Injection — Second-Generation Parenteral Cephalosporin

Cefob-1.5g Injection — Cefuroxime Sodium 1500 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Cefuroxime Sodium 1500 mg
Dosage Form Injection (IV/IM)
Pack Type Vial
Pack Size 1 Vial of 1.5 g
MRP ₹ 345
Therapy Injectable + Antibiotic — Second-Generation Cephalosporin (Parenteral)
Storage Store below 25 °C in a dry place, protected from light. After reconstitution, use within 24 hours.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Cefob-1.5g Injection

Cefob-1.5g Injection contains Cefuroxime Sodium 1500 mg — the high-strength parenteral cephalosporin used for serious bacterial infections requiring IV antibiotic coverage. It is widely used in hospitals for community-acquired pneumonia, complicated skin/soft-tissue infections, bone and joint infections and as surgical prophylaxis.

Cefuroxime’s second-generation spectrum bridges the gram-positive coverage of first-generation cephalosporins with extended gram-negative activity against H. influenzae, M. catarrhalis and selected Enterobacteriaceae. It is also effective against many penicillinase-producing organisms due to its beta-lactamase stability.

Cefob-1.5g is manufactured by Trumac Healthcare under WHO-GMP injectable conditions. Available for monopoly-based PCD pharma franchise, government tenders and third-party manufacturing — a hospital staple SKU.

Indications

  • Community-acquired pneumonia
  • Complicated skin and soft-tissue infections
  • Bone and joint infections
  • Septicaemia and bacteraemia
  • Pre- and post-surgical prophylaxis
  • Meningitis (in combination with other agents)

Mechanism of Action

Cefuroxime is a second-generation cephalosporin that binds penicillin-binding proteins, inhibiting peptidoglycan cross-linking and producing bacterial cell wall destabilisation. Compared with first-generation cephalosporins, cefuroxime has enhanced gram-negative activity (H. influenzae, M. catarrhalis, E. coli) plus retained gram-positive coverage.

Dosage & Administration

Adults: 750 mg–1.5 g IV/IM every 8 hours, depending on infection severity. Children: 30–100 mg/kg/day in divided doses. Adjust dose in renal impairment. Strictly hospital use under medical supervision.

Side Effects

Diarrhoea, nausea, vomiting, mild skin rash. Rare: pseudomembranous colitis, anaphylaxis, severe skin reactions, transient hepatic enzyme elevation. Cross-reactivity with penicillin allergy (~5–10%). Injection site reactions, pain, phlebitis with IV use.

Contraindications & Precautions

Hypersensitivity to cephalosporins. Severe penicillin allergy. Caution in renal impairment (dose adjustment). Caution in GI disease.

Storage

Store below 25 °C in a dry place, protected from light. After reconstitution, use within 24 hours.

PCD Pharma Franchise & Third-Party Manufacturing
Cefob-1.5g Injection is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Cefob-1.5g Injection used for?

Cefob-1.5g Injection contains Cefuroxime 1500 mg for serious bacterial infections — community-acquired pneumonia, complicated skin and bone/joint infections, septicaemia and surgical prophylaxis.

How is Cefob-1.5g administered?

By IV bolus, IV infusion or IM injection, every 8 hours, calculated by clinical severity and body weight. Strictly hospital use by trained medical personnel.

Is Cefob-1.5g available for PCD pharma franchise?

Yes, Trumac Healthcare offers Cefob-1.5g Injection on monopoly-based PCD pharma franchise, government tenders and third-party manufacturing.

How should Cefob-1.5g be stored?

Store below 25 °C in a dry place, protected from light. After reconstitution, use within 24 hours (refrigerate the unused reconstituted vial).

Is Cefob-1.5g WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant injectable facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.